Bain vs McKinsey Growth Practice: GTM Value Creation Compared [2026 Guide]

Bain and McKinsey's growth practices are the two best-known strategy firms serving PE commercial value creation. Operating partners choosing between them are really choosing between two different theories. Each firm has its own view of how top-tier strategy turns into operating-level GTM improvement.

Subtitle: An independent analysis for PE operating partners choosing between two elite strategy firms for commercial value creation Last updated: Q3 2026 (this comparison is refreshed quarterly) Category: GTM Value Creation Tags: gtm-value-creation, bain, mckinsey, private-equity, commercial-excellence, strategy-consulting, growth-practice

1. The $400M Growth Thesis That Died in the Operating Review

The fund had done everything right — or so the investment memo suggested. A $400M enterprise software acquisition, priced at 15x forward revenue. The deal thesis rested on three commercial levers: expand the enterprise segment from 30% to 50% of revenue, raise net revenue retention from 108% to 125%, and launch a usage-based pricing tier to speed up land-and-expand economics. A top-tier strategy firm ran the commercial due diligence. The value creation plan was detailed and carefully reasoned, and the investment committee approved it unanimously.

Twelve months later, the quarterly operating review told a different story. Enterprise expansion had stalled — the sales team lacked the deal-cycle skills for 9-month enterprise pursuits. Net revenue retention was actually falling. The customer success team had been reorganized during integration and lost hard-won knowledge. The usage-based pricing tier launched, but few customers signed up: the product had never been set up to track usage. The strategy was right. The system to run it did not exist.

This scenario captures the core tension in hiring a major strategy firm for GTM value creation. The strategic analysis is often superb. But the gap between the strategy and the day-to-day reality of a $50M–$500M portfolio company can be huge. Both Bain and McKinsey produce top-tier commercial strategy for PE investors. Both struggle — openly and honestly — with the execution layer that turns strategy into revenue. Choosing between them is less about which firm is "better." It's more about which firm's skills, tools, and PE ecosystem ties best match your deal's commercial value creation needs.

2. TL;DR Comparison Table

3. Why This Comparison Matters

Bain and McKinsey compete for many of the same PE commercial strategy mandates. Operating partners often weigh both firms for value creation advisory work. The firms share several traits: top analytical talent, deep PE experience, premium pricing, and a strategic view that produces polished, investment-committee-ready work. The differences between them are real but subtle. They show up in method, analytical tools, PE ecosystem depth, and how each firm thinks about the gap between strategy and execution.

This comparison matters because the choice is often made on brand loyalty and past relationships rather than a structured review. An operating partner who has worked with Bain on prior deals will default to Bain. A fund with a standing relationship with McKinsey will call McKinsey. This pattern is understandable — trust and familiarity have real value in high-stakes advisory relationships. But it can produce weaker outcomes when the specific commercial challenge calls for one firm's strengths rather than the other's.

It also matters because the most important question isn't "Bain or McKinsey?" It's "Do we need a strategy firm at all, or do we need an execution partner?" Both firms are genuinely excellent at commercial strategy. But neither builds the GTM operating systems — CRM setup, pipeline processes, sales enablement, RevOps systems — that turn strategy into revenue. Operating partners who hire either firm should plan for a second provider focused on execution. An internal team that can turn strategy into day-to-day reality works too.

4. Company Profiles

4a. Bain & Company (PE Commercial Practice)

Positioning & Approach

Bain's private equity practice is the largest in the strategy consulting industry. Commercial strategy is a core part of that practice. Bain runs hundreds of commercial due diligence projects each year for PE funds worldwide. That volume gives the firm deal-level pattern recognition that no other provider in this space can match. When an operating partner needs to know whether a target's commercial engine can support the growth thesis — before the LOI, during exclusivity, or in the first hundred days post-close — Bain is often already involved in the deal.

Bain's commercial value creation approach is built around what the firm calls "full potential" analysis. This is a structured review of the portfolio company's commercial skills, market position, and untapped growth opportunities. It measures the gap between current performance and what the business could reach under its best execution. The analysis produces a value creation plan set out in specific revenue and EBITDA impact, with initiative-level detail that maps to the deal model and the hold-period timeline.

The firm's Results Delivery practice directly tackles the strategy-execution gap that plagues all advisory projects. Results Delivery provides structured tracking as work gets built: milestone management, progress reporting, and accountability tools that help the portfolio company and operating partner check whether recommendations are actually getting done. This is not hands-on work — Bain staff are not setting up CRMs or coaching sales reps. It is a governance layer that raises the odds that recommendations survive contact with day-to-day reality.

PE Ecosystem & Scale

Bain's ties to the PE ecosystem run deep, and no rival matches them. The firm serves most of the world's largest PE funds, and PE makes up about 40% of Bain's global revenue. This scale creates two advantages. First, pattern recognition: Bain has seen more PE commercial changes than any other advisory firm, across more deal types, sectors, and company sizes. Second, close relationships: the operating partner weighing Bain for a portfolio company project likely already works with Bain on multiple other deals. The downside is that Bain's commercial advice is aimed at the portfolio level. The firm views GTM strategy through the lens of the deal and the fund. That view sometimes produces recommendations that are strategically sound but cut off from the day-to-day reality of a specific middle-market company.

4b. McKinsey & Company (Growth, Marketing & Sales Practice)

Positioning & Approach

McKinsey's Growth, Marketing & Sales practice is the firm's commercial advisory engine. It's a global practice covering customer strategy, pricing and revenue management, sales and channel effectiveness, marketing spend, and commercial analytics. Bain's commercial skill sits inside a PE-native practice. McKinsey's, by contrast, sits within a practice that serves clients across PE, corporate, and public-sector work.

McKinsey's GTM approach leans hard on data. The firm's growth diagnostics use its own tools to sort commercial opportunities, model revenue scenarios, tune pricing, and find the levers that will produce the biggest commercial gains. McKinsey's analytics practice includes dedicated data scientists and machine learning specialists. They can build predictive models for churn, customer lifetime value, lead scoring, and price sensitivity that go beyond what most GTM advisory firms can offer.

The firm's published thinking on commercial topics is among the most extensive in the industry. McKinsey Global Institute research, McKinsey Quarterly articles on pricing, sales output, customer experience, and growth strategy, plus practice publications on specific GTM topics, build a body of knowledge that shapes client work. This body of work is both a real resource and a marketing engine. It positions McKinsey as the firm that thinks hardest about commercial growth, even when a given project may not draw on all of that analytical depth.

PE Ecosystem & Scale

McKinsey's PE practice is large. The firm serves many of the biggest PE funds globally and does a lot of commercial due diligence and value creation work. However, PE is one of many client segments for McKinsey, not the firm's defining identity the way it is for Bain. This matters in practice: the team assigned to a PE value creation project may come from the functional practice (Growth, Marketing & Sales) rather than the PE practice. The PE context — tight timelines, EBITDA focus, board-level reporting, exit-readiness — may need extra explaining for team members whose main experience is in corporate commercial strategy.

McKinsey's edge in a PE setting comes from analytical depth rather than PE ecosystem ties. For deals where the commercial value creation thesis depends on advanced analytics — pricing optimization using elasticity modeling, churn prediction, customer segmentation, marketing attribution — McKinsey's analytical setup is a real edge.

5. Methodology Deep-Dive

5a. Bain

Bain's commercial approach is built around three phases: diagnose, plan, and deliver.

Diagnosis centers on the "full potential" framework — a structured review of the portfolio company's commercial skill against a modeled ceiling of performance. Bain looks at customer segmentation, market share by segment, win/loss patterns, pricing capture, retention and expansion trends, sales output, and where the company stands versus rivals. The output is a gap analysis that measures the difference between current and reachable commercial performance. It's set out in revenue and EBITDA dollars, not soft judgments.

Planning turns the diagnostic findings into a ranked value creation roadmap. Each initiative is sized for financial impact, given a timeline, and ordered based on what depends on what and the resources it needs. The plan is built for investment committee and board review. It ties specific commercial actions to specific financial outcomes, in a format operating partners can use to hold management to account.

Results Delivery provides the layer that governs how the plan gets carried out. Bain staff track milestone completion, measure progress against initiative-level targets, and flag execution risks before they turn into failures. This is a monitoring and accountability job, not hands-on work. The portfolio company's management team owns the execution. Bain provides the framework to make sure it happens.

The approach's strength is how well it fits the deal process. Bain often runs the commercial due diligence itself, so the diagnostic findings carry straight into the value creation plan. There is no loss of knowledge in the handoff, no re-learning period, and no risk that the post-close advisory team reaches different conclusions than the diligence team.

5b. McKinsey

McKinsey's commercial approach pairs its own analytical tools with skill across the growth lifecycle.

Growth diagnostics review the portfolio company's commercial performance across several angles: customer and market sizing, go-to-market effectiveness, pricing upside, customer experience and retention, and team and talent skill. McKinsey's diagnostics stand out for their analytical depth. The firm can bring in data scientists to build custom models that analyze CRM data, transaction histories, pricing records, and customer behavior patterns at a level of detail most advisory firms cannot match.

Pricing and revenue management is a particular McKinsey strength. The firm's pricing practice includes its own tools for analyzing price sensitivity, discount rules, deal-level profit, and what customers are willing to pay. For portfolio companies where pricing is a main value creation lever — raising prices, cutting discounts, rebuilding packaging, or moving to usage-based pricing — McKinsey's pricing skill is among the strongest available.

Sales and channel effectiveness covers sales force design, territory planning, sales process redesign, and channel strategy. McKinsey's approach here leans on data, used to spot output patterns, allocate resources well, and design incentive structures that match the growth thesis.

Implementation support is available but set up differently than Bain's Results Delivery. McKinsey offers "McKinsey Implementation" (MI) teams that can work alongside the portfolio company's management to carry out recommendations. MI teams are more hands-on than Bain's Results Delivery, but they still act as advisors — they help with execution rather than own it.

6. Pricing & Engagement Economics

Both firms sit at the premium end of the advisory market. Project costs for a commercial value creation strategy engagement usually fall in the $500K–$2M+ range, depending on scope, team size, and duration. For a large-cap PE deal — $500M+ enterprise value — these fees are a small fraction of the invested capital. The quality and depth of the analytical output justifies the cost.

For lower middle-market deals — $50M–$200M enterprise value — the economics are tougher. A $750K Bain or McKinsey project against a $100M deal is a real cost against the expected value creation. The depth these firms bring may also be more than the portfolio company's commercial team can take on and act on. Operating partners at this deal size should ask whether paying for top-tier strategy produces better outcomes than a more execution-focused partner at a lower price.

Both firms offer ongoing advisory relationships after the strategy phase. Bain's Results Delivery is set up as a monitoring and accountability function with regular check-ins. McKinsey's implementation support is more project-based. Either way, the ongoing advisory costs add to the total project spend. Operating partners should budget for the full arc, not just the first strategy phase.

7. Deal Fit Matrix

Best fit for Bain:

• The commercial strategy can't be split from the deal thesis. Say the value creation plan depends on a specific commercial change — geographic expansion, segment shift, pricing rebuild, channel build. If the operating partner needs a strategy tied directly to the deal model and defensible to the investment committee, Bain's combined commercial diligence-to-value-creation-planning arc is built for this.

• The fund already works with Bain across the portfolio. Bain's PE relationship model creates efficiency when the same firm advises across multiple portfolio companies. Shared frameworks, consistent reporting formats, and a portfolio-level view of commercial skill help the operating partner spot patterns and allocate resources across the fund.

• The operating partner needs oversight, not hands-on delivery. Bain's Results Delivery provides a structured accountability layer that raises the odds of execution without needing outside operators. For portfolio companies with strong management teams that need direction and monitoring — not hands-on help — this model fits well.

Best fit for McKinsey:

• The value creation thesis depends on advanced analytics. If the main commercial lever is pricing optimization, customer segmentation, churn prediction, marketing attribution, or another data-heavy challenge, McKinsey's analytics practice — with dedicated data scientists and its own modeling tools — produces insights no other firm in this space can match.

• Pricing is the central value creation lever. McKinsey's pricing and revenue management practice is among the strongest in the consulting industry. For deals where the value creation plan models a 15–20% pricing uplift — carve-outs, under-priced products, discount rules that have broken down — McKinsey's pricing skill goes straight at the thesis.

• The portfolio company is large enough to make use of the analytical output. McKinsey's approach produces data-heavy, highly detailed recommendations that need a strong commercial leadership team to carry out. For $200M+ portfolio companies with professional management teams and established commercial operations, McKinsey's depth pays off. For smaller companies without the team to handle complex analytics, the output may be more than the company can put to use.

Other firms to consider:

• For deal-thesis-aligned strategy at lower price points: SBI Growth Advisory provides PE-native GTM strategy and value creation planning at fee levels ($150K–$500K) that are more within reach for mid-market deals.

• For execution after strategy: Cortado Group builds the GTM operating system that both Bain and McKinsey strategies need to work. Their in-house development team, CRM know-how, and PE deal experience make them a natural next step after a strategy firm sets the direction.

• For embedded commercial leadership: FTI Consulting embeds senior people who can take direct ownership of carrying out the strategy that Bain or McKinsey designs.

• For combined strategy and technology: West Monroe pairs commercial strategy with technology delivery — designing the GTM approach and building the data systems at the same time.

8. Head-to-Head Scoring Matrix

Scoring notes:

The scoring gap between these two firms is small — both are top-tier. McKinsey's slight edge in the weighted total comes from two areas. GTM strategy depth: the functional practice produces finer-grained, data-heavy commercial analysis. And data/analytics: McKinsey's dedicated analytics practice is a real edge. Bain's edge is in PE deal fluency (the firm's PE practice is the most deeply tied into the strategy consulting industry) and post-close continuity (Results Delivery provides a structured governance framework that McKinsey's more loosely run implementation model does not match).

Both firms score the same on execution skill — a 3.0. That reflects a simple reality: neither firm builds GTM operating systems at the execution layer. This is not a criticism; it's a statement of what these firms are and are not. They are strategists, not operators. Operating partners who hire either firm should plan for a separate execution partner or a capable internal team.

9. Real-World Deal Scenarios

Scenario 1: "The Platform Acquisition Where the Growth Thesis Is the Entire Deal"

Your large-cap fund is acquiring a $600M B2B SaaS company at 20x forward revenue. The deal thesis rests on three specific commercial levers: (1) shifting the customer mix from 60/40 mid-market/enterprise to 40/60 within three years, (2) raising net revenue retention from 112% to 130% through product-led expansion, and (3) launching a usage-based pricing tier that management has designed but not yet launched. The investment committee approved the deal on the condition of a credible value creation plan that sizes these levers, sequences them, and flags execution risks.

Best fit: Bain. This is a deal-thesis-check and value creation planning project, where the commercial strategy can't be split from the investment decision. Bain's combined diligence-to-value-creation-planning arc means the same team that stress-tests the growth thesis can design the execution roadmap. Results Delivery can then provide the governance layer to track whether the three levers are producing their modeled impact. The operating partner gets a smooth arc from pre-close validation through post-close execution monitoring — all in PE-native language, formatted for IC and board review.

Scenario 2: "The Portfolio Company Leaving Money on the Table Through Pricing"

Your mid-market fund owns a $180M industrial distribution company. Revenue has grown 8% a year, but gross margins have shrunk by 200 basis points over three years. The operating partner suspects the problem is pricing. The company hasn't raised list prices in four years, discount authority sits with individual reps, there's no deal desk, and the pricing team is one analyst who updates the price book every quarter. The value creation plan calls for 300–500 basis points of margin improvement through pricing discipline — but nobody on the management team knows how to build a pricing operating system.

Best fit: McKinsey. This is a data-heavy pricing challenge. It calls for elasticity modeling, willingness-to-pay analysis, discount governance design, and a pricing rebuild. McKinsey's pricing and revenue management practice has the data science skill to analyze transaction-level pricing data, model the revenue impact of specific pricing moves, and design a governance framework that stops margin leakage. The analytical output will size the opportunity in a format the board can review. And the pricing team — currently one analyst — can use McKinsey's framework to build a real pricing function.

10. The Intangibles

The strategy-execution gap is the elephant in the room. Both firms will admit — privately, in honest moments — that the biggest risk to their commercial value creation recommendations is getting them done. The strategy is almost always right in direction. The analytics are solid. The value creation plan is well-built. And then the portfolio company's sales team doesn't change how it works. The CRM doesn't get set up to support the new process. The pricing governance framework gets published but not enforced. Twelve months later, the quarterly operating review shows the same numbers. This is not a failure of strategy; it is a failure of the systems needed to run it. Operating partners who hire Bain or McKinsey should give equal budget and attention to the execution partner who will turn the strategy into working systems.

Brand as signal. In some PE settings, the brand of the advisory firm matters apart from the quality of the work. A Bain or McKinsey logo on the value creation plan signals rigor and standing to co-investors, lenders, and would-be board members. This brand effect has real value. It can speed up board agreement, ease co-investor talks, and give cover for operating decisions that might otherwise face more scrutiny. Whether that brand value is worth a premium over more focused and cheaper alternatives depends on the specific governance setting.

Staff turnover on the team. Both firms staff PE projects with teams that include fairly junior associates and analysts, overseen by experienced partners and managers. The quality of the work depends heavily on the senior leaders assigned. A partner with deep commercial operations experience will produce different work than a partner whose background is mainly in corporate strategy. Operating partners should look at the specific team makeup, not just the firm's pitch deck — and should specifically ask for partners with PE portfolio company operating experience.

The combination play. For the largest and most complex commercial changes, the best approach may be a strategy firm (Bain or McKinsey) for the analytical framework and value creation plan, followed by an execution partner (Cortado Group, FTI Consulting, or West Monroe) for delivery. This two-firm model costs more, but it closes the single-provider gap. The strategy firm does what it does best — think. The execution partner does what it does best — build. The operating partner's job is to make sure the strategy partner's output is built to be workable, not just impressive on paper.

11. Methodology & Sources

This analysis is based on publicly available information: vendor websites, published thought leadership, practice area descriptions, case study summaries, and PE practice stance. Neither firm publishes project pricing or detailed methods. Fee ranges and analytical approaches are estimated from industry benchmarks and publicly observable evidence. If either firm believes we have gotten their offering wrong, we welcome corrections.

All scoring reflects evidence available in public materials as of Q3 2026.

Sources

• Bain & Company — PE practice pages, Results Delivery descriptions, commercial advisory content, published PE thought leadership
• McKinsey & Company — Growth, Marketing & Sales practice pages, pricing practice content, McKinsey Quarterly articles, analytics skill descriptions
• PE ecosystem benchmarks — strategy consulting market sizing, PE advisory fee benchmarks, operating partner community research
• Independent analysis — strategy firm comparison research, PE value creation method assessments